| Nr. | Numelestudiului | Status | Locatia/Locatiilestudiului |
| 1 | Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy. | Activ, inca nu recruteaza | SC Oncolab SRL, Craiova, Dolj, Romania, 200385S.C. Oncocenter Oncologie Clinica S.R.L., Timisoara, Timis, Romania, 300166SC ONCOCENTER Oncologie Clinica SRL, Timisoara, Timis, Romania, 300210Spitalul Clinic C.F. 2 Bucuresti. Departament Oncologie, Sectia Medicala 2, Bucuresti, Romania, 011464 |
| 2 | Pan Tumor Nivolumab Rollover Study | In curs de recrutare | Local Institution, Bucharest, Romania, 022328, Contact: Site 0129 Local Institution, Cluj Napoca, Romania, 400015, Contact: Site 0135 Local Institution, Cluj Napoca, Romania, 400641, Contact: Site 0127 Local Institution, Oradea, Romania, 440445, Contact: Site 0133 |
| 3 | A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) (CheckMate 848) | In curs de recrutare | Local Institution, Bucuresti, Romania, 022328Local Institution, Cluj-Napoca, Romania, 400015Local Institution, Craiova, Romania, 200347Local Institution, Floresti, Romania, 407280Local Institution, Timisoara, Timis, Romania, 300239 |
| 4 | Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) | Activ, inca nu recruteaza | S.C Delta Health Care S.R.L, Bucuresti, Romania, 014142S.C Medisprof S.R.L., Cluj-Napoca, Romania, 400641S.C Centrul de Oncologie Sf. Nectarie S.R.L., Craiova, Romania, 200347S.C Oncocenter Oncologie Clinica S.R.L., Timişoara, Romania, 300166 |
| 5 | Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002) | In curs de recrutare | S.C. Pelican Impex S.R.L Spitalul Clinic Pelican Oradea ( Site 1102), Oradea, Bihor, Romania, 410469, Contact: Study Coordinator +40746103306 SC Radiotherapy Center Cluj SRL ( Site 1105), Comuna Floresti, Cluj, Romania, 407280, Contact: Study Coordinator +40742206212 S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1103), Craiova, Dolj, Romania, 200347, Contact: Study Coordinator +40727774974 Spitalul PDR Medlife ( Site 1106), Brasov, Romania, 500152, Contact: Study Coordinator +40722559551 S.C.Focus Lab Plus S.R.L ( Site 1101), Bucuresti, Romania, 021389, Contact: Study Coordinator +40721298677 S.C.Gral Medical S.R.L ( Site 1104), Bucuresti, Romania, 031422, Contact: Study Coordinator +40723954705 Medisprof ( Site 1107), Cluj Napoca, Romania, 400641, Contact: Study Coordinator +40751274636 |
| 6 | Study of Romiplostim for Chemo-induced Thrombocytopenia in Adults Subjects With Gastrointestinal or Colorectal Cancer | In curs de recrutare | Research Site, Bucharest, Romania, 022328Research Site, Cluj-Napoca, Romania, 400015Research Site, Cluj-Napoca, Romania, 400124Research Site, Timisoara, Romania, 300239 |
| 7 | An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread | In curs de recrutare | Local Institution, Bucharest, Romania, 022328, Contact: Site 0045 Local Institution, Craiova, Romania, 200347, Contact: Site 0041 |
| 8 | A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A) | In curs de recrutare | Prof. Dr. I. Chiricuta Institute of Oncology, Cluj Napoca, Romania, 400015Institut Oncologic Ion Chiricuta; Departament Radioterapie, Cluj-napoca, Romania, 400015ONCOMED – Medical Centre, Timisoara, Romania, 300239 |
| 9 | Durvalumab Long-Term Safety and Efficacy Study (WAVE) | In curs de recrutare | Research Site, Craiova, Romania, 200347Research Site, Suceava, Romania, 720237 |
| 10 | A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella B) | In curs de recrutare | Centrul de Oncologie Sfantul Nectarie, Craiova, Romania, 200347 |
| 11 | Avelumab Program Rollover Study | In curs de recrutare | Spitalul Clinic Municipal „Dr. Gavril Curteanu” Oradea – Centrul Oncologie Medicala, Oradea, Romania, 410469, Contact: simonamihutiu@yahoo.com, Principal Investigator: Simona Mihutiu |
| 12 | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | Activ, inca nu recruteaza | Novartis Investigative, Bucuresti, Romania, 011863 |
| 13 | AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study. (CONTI-PV) | Activ, inca nu se recruteaza | Emergency Clinical County Hospital Brasov, Brasov, RomaniaBucharest University Emergency Hospital, Bucharest, RomaniaColtea Clinical Hospital, Bucharest, Romania |
| 14 | A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes (EUMDS) | In curs de recrutare | Fundeni CLinical Institute, Clinic of Hematology, Bucharest, Romania |
| 15 | NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall | Activ, inca nu se recruteaza | Institutul Oncologic Bucuresti Bucharest, Romania Spitalului Universitar de Urgenta Militar Central Bucharest, Romania Amethyst-Cluj Floresti, Romania County Hospital ‘Dr Gavril Curteanu’ Oradea, Romania County Hospital, Targu Mures Targu Mures, Romania Municipal Emergency Hospital Timisoara, Romania |
(Visited 73 times, 1 visits today)